Alpha Q Advisors LLC Abb Vie Inc. Transaction History

Alpha Q Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $40,477 - $46,858	-303 Reduced 13.89%	1,879 $280 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $117,536 - $146,266	887 Added 68.49%	2,182 $294 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $95,587 - $110,082	-661 Reduced 33.79%	1,295 $206 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $270,534 - $324,441	1,956 New	1,956 $316 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Alpha Q Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Q Advisors LLC with notifications on news.